Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:ARWR
Date10/2000
Raised
Post IPO Valuation

General Information

Offices

Pasadena, USA
201 South Lake Avenue
Suite 703
Pasadena, CA, 91101
USA

People

Chairman, Board of Directors
CFO
Chief Operating Officer
President and CEO
Board of Directors
Board of Directors
Board of Directors
Chief Business Officer
Show All People

Investments

Funding

TOTAL $66M
FUNDING TOTAL $2.76M
Venture Round, 8/2009
$2.76M
POST IPO FUNDING TOTAL $63.2M
Post IPO Equity, 1/2010
$3.22M
Post IPO Equity, 10/2013
RA Capital Management
$60M

Tags

Arrowhead Research

Arrowhead Research Corporation, through its subsidiaries, identifies advances in nanotechnology and matches them with product development opportunities in high-growth markets, focusing on the electronics and biotech industries. It focuses on developing, commercializing, and licensing a range of nanotechnology products and applications, including anti-cancer drugs, RNAi therapeutics, regenerative therapeutics, advanced drug delivery technology, energy storage technology, carbon-based electronics, and fullerene anti-oxidants. The company has developed Cyclosert, a proprietary drug delivery platform technology based on a nano-engineered class of linear cyclodextrin-containing polymers. Its lead anti-cancer drug candidate IT-101 is a combination of Cyclosert and the potent anti-cancer drug, camptothecin, is under Phase I clinical trials. Arrowhead Research also focuses on the design, development, and commercialization of novel RNA interference (RNAi) therapeutics to treat diseases and other medical conditions by combining RNAi therapeutics with patented and proprietary delivery technologies. Its CALAA-01 product is a formulation of proprietary delivery technology with a siRNA duplex targeting the M2 subunit of ribonucleotide reductase. In addition, the company engages in the manufacture and application of carbon nanotubes-based products for the electronics industry. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.

Recent Milestones

Videos

Screenshots

Arrowhead Research screenshot
Above: Homepage
Uploaded: 3/21/14

Stock Price

Sources

  1. ARROWHEAD INCREASES INVESTMENT IN RNAI SUBSIDIARY CALANDO PHARMACEUTICALS (freshnews.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. Arrowhead Research Raises $60M In PIPE (socaltech.com) [edit]
  5. Arrowhead Announces Offering of Common Stock and Warrants (freshnews.com) [edit]
    Arrowhead Research Corporation Acquires Roche RNA Assets and Site (freshnews.com) [edit]
    Arrowhead Closes Private Offering with Net Proceeds of $60 Million (bioportfolio.com) [edit]
Edit This Page
Last Edited 3/21/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy